How to assess endothelial function in human blood vessels

Journal of Hypertension

Volumn 17, Issue 8, 1999, Pages 1047-1058

  Vanhoutte, Paul M ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Cyclooxygenase; Endothelin; Endothelium derived hyperpolarizing factor; Gap junctions; Human blood vessels; Nitric oxide; Prostacyclin; Superoxide anions

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; ENDOTHELIN; NITRIC OXIDE; VASOCONSTRICTOR AGENT;

ARTERY; BLOOD VESSEL DIAMETER; CIRCULATION; HUMAN; HYPERPOLARIZATION; IN VITRO STUDY; ISOLATED ARTERY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VEIN;

EID: 0032810015     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917080-00001     Document Type: Review

References (200)

1. 1 Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
2. 2 Vanhoutte PM. State of the art lecture. Endothelium and responsiveness of vascular smooth muscle. J Hypertens 1987; 5:S115-S120.
3. 3 Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3:2007-2017.
4. 4 Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, Florida: CRC Press Inc.; 1990.
5. 5 Pearson PJ, Vanhoutte PM. Vasodilator and vasoconstrictor substances produced by endothelium. Rev Physiol Biochem Pharmacol 1993; 122:1-67.
6. 6 Miller VM, Vanhoutte PM. Endothelium-dependent responses in isolated blood vessels of lower vertebrates. Blood Vessels 1986; 23:225-235.
7. 7 De Mey JG, Claeys M, Vanhoutte PM. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther 1982; 222:166-173.
8. 8 Vanhoutte PM. The other endothelium-derived vasoactive factors. Circulation 1993; 87(suppl V):V9-V17.
9. 9 Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP. Circulation 1995; 92:3337-3349.
10. 10 Mombouli JV, Vanhoutte PM. Endothelium-derived hyperpolarizing factor(s). Updating the unknown. Trends Pharmacol Sci 1997; 18:252-256.
11. 11 De Mey JG, Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall: importance of the endothelium. Circ Res 1982; 51:439-447.
12. 12 De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol 1983; 335:65-74.
13. 13 Vanhoutte PM. Endothelium-dependent contractions in arteries and veins. Blood Vessels 1987; 24:141-144.
14. 14 Vanhoutte PM, Lüscher TF, Gräser TF. Endothelium-dependent contractions. Blood Vessels 1991; 28:74-83.
15. 15 Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993; 21:747-751.
16. 16 Roy SS, Saifededine M, Loutzenhiser R, Triggle CR, Hollenberg MD. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 1998; 123:1434-1440.
17. 17 Vanhoutte PM, Houston DS. Platelets, endothelium and vasospasm. Circulation 1985; 72:728-734.
18. 18 Vanhoutte PM. Could the absence or malfunction of vascular endothelium precipitate the occurrence of vasospasm? J Mol Cell Cardiol 1986; 18:679-689.
19. 19 Vanhoutte PM. The endothelium - modulator of vascular smooth-muscle tone. N Engl J Med 1988; 319:512-513.
20. 20 Vanhoutte PM. Hypercholesterolaemia, atherosclerosis and release of endothelium-derived relaxing factor by aggregating platelets. Eur Heart J 1991; 12:25-32.
21. 21 Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993; 87 (suppl V):V36-V44.
22. 22 Vanhoutte PM. Endothelial dysfunction in hypertension. J Hypertens 1996; 14:S83-S93.
23. 23 Angus JA. Role of the endothelium in the genesis of cardiovascular disease. Clin Exp Pharmacol Physiol 1996; 23 (suppl 1):S16-S22.
24. 24 Vanhoutte PM. Endothelial dysfunction and vascular disease. In: Cannon RO III, Panza JA (editors): Vascular biology: endothelium, nitric oxide and atherosclerosis. New York, USA: Futura Publishing Company Inc (in press).
25. 25 Holtz J, Giesler M, Bassenge E. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilatation and direct smooth muscle relaxation. Z Kardiol 1983; 72:98-106.
26. 26 Vedernikov YP, Aarhus L, Shepherd JT, Vanhoutte PM. Postmortem changes in endothelium-dependent and independent responses of porcine coronary arteries. Gen Pharmacol 1990; 21:49-52.
27. 27 McNally PG, Watt PAC, Rimmer T, Burden AC, Heamshaw JR, Thurston H. Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci 1994; 87:31-36.
28. 28 Deng LY, Li JS, Schiffrin E. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci 1995; 88:611-622.
29. 29 Chin-Dusting JPF, Alexander CT, Arnold PJ, Hodgson WC, Lux AS, Jennings GLR. Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. J Cardiovasc Pharmacol 1996; 28:158-166.
30. 30 Goode GK, Garcia S, Heagerty AM. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hyporcholesterolemic patients. A double-blind placebo-controlled study. Circulation 1997; 96:2802-2807.
31. 31 James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Endothelial function in subcutaneous resistance arteries from elderly hypertensive and normotensive subjects. Clin Sci 1997; 92:139-145.
32. 32 Blaise G, Sill JC, Nugent M, Van Dyke RA, Vanhoutte PM. Isoflurane causes endothelium-dependent inhibition of contractile responses of canine coronary artenes. Anesthesiology 1987; 67:513-517.
33. 33 Kessler P, Lischke V, Hecker M. Etomidate and thiopental inhibit the release of endothelium-derived hyperpolarizing factor in the human renal artery. Anesthesiology 1996; 84:1485-1488.
34. 34 Higueras J, Sarriá B, Ortiz JL, Cortijo J, Maruenda A, Barberá M, et al. Halothane inhibits endothelium-dependent relaxation elicited by acetylcholine in human isolated pulmonary arteries. Eur J Pharmacol 1997; 326:175-181.
35. 35 Kerth PA, Vanhoutte PM. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. Am J Hypertens 1991; 4:226S-234S.
36. 36 Mombouli JV, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 1991; 18 (suppl 2):II22-II29.
37. 37 Mombouli JV, Vanhoutte PM. Heterogeneity of endothelium dependent vasodilator effects of angiotengin-converting enzyme-inhibitors: rule of bradykinin generation during ACE inhibition. J Cardiovasc Pharmacol 1992; 20 (suppl 9):S74-S82
38. 38 Vidal M, Joly G, Mombouli JV, Boulanger CM, Vanhoutte PM. The endothelium and vascular effects of the ACE inhibitor trandolaprilat. J Cardiovasc Pharmacol 1994; 23:S1-S5.
39. 39 O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95:1126-1131.
40. 40 Neunteufl T, Kostner K, Katzenschlager R, Zehetgruber M, Maurer G, Weidinger F. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J Am Coll Cardiol 1998; 32:711-716.
41. 41 Vilaine JP, Biondi ML, Villeneuve N, Félétou M, Peglion JL, Vanhoutte PM. The calcium channel antagonist S11568 causes endothelium-dependent relaxation in canine arteries. Eur J Pharmacol 1991; 197:41-48.
42. 42 Rubanyi GM, Hoeffner U, Schwartz A, Vanhoutte PM. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries. J Pharmacol Exp Ther 1988; 246:60-64.
43. 43 Perticone F, Ceravolo R, Maio R, Ventura G, Iacopino S, Cuda G, et al. Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients. Cardiovasc Res 1999; 41:299-306.
44. 44 Taddei S, Virdis A, Ghiadoni L, Salvetti A. Endothelial function in human hypertension: potential of calcium antagonists. J Cardiovasc Pharmacol 1997; 30 (suppl 3):S18-S26.
45. 45 Rogors PJ, Miller TD, Bauer BA, Brum JM, Bove AA, Vanhoutte PM. Exercise training and responsiveness of isolated coronary arteries. J Appl Physiol 1991; 71:2346-2351.
46. 46 Mombouli JV, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training. Br J Pharmacol 1996; 117:413-418.
47. 47 Raij L, Lüscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension 1988; 12:562-567.
48. 48 Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and in atherosclerosis. Circ Res 1989; 64:900-914.
49. 49 Voors AA, Oosterga M, Buikema H, May JF, Grandjean JG, van Buiten A, et al. Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery. Cardiovasc Res 1997; 34:568-574.
50. 50 Shimokawa H, Lam JY, Chesebro T, Bowie JH, Walter, EJ, Vanhoutte PM. Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation 1987; 76:898-905.
51. 51 Shimokawa H, Aarhus LL, Vanhoutte PM. Dietary omega-3 polyunsaturated fatty acids augment endothelium-dependent relaxation to bradykinin in porcine coronary microvessels. Br J Pharmacol 1988; 95:1191-1196.
52. 52 Shimokawa H, Vanhoutte PM. Dietary omega-3 fatty acids and endothelium-dependent relaxations in porcine coronary arteries. Am J Physiol 1989; 256:H968-H973.
53. 53 McDowell IFW, Brennan GM, McEneny J, Young IS, Nicholis DP, McVeigh GE, et al. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur J Clin Invest 1994; 24:759-765.
54. 54 Timini FK, Henry HT, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998; 31:552-557.
55. 55 Horning B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998; 97:363-368.
56. 56 Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32:1672-1679.
57. 57 Green D, O'Driscoll G, Rankin JM, Maiorana AJ, Taylor RR. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin Sci 1998; 95:361-367.
58. 58 Fitzpatrick DV, Hirschfield SL, Goffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993; 265:H774-H778.
59. 59 Andriambeloson E, Stoclet JC, Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol 1999; 33:248-254.
60. 60 Gisclard V, Miller V, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988; 244:19-22.
61. 61 Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991; 261:R1022-R1027.
62. G-monomethyl-L-arginine in post-partum and non-pregnant women. Clin Sci 1996; 90:493-497.
63. 2+ mobilization. Circ Res 1997; 81:885-892.
64. 64 Cockell AP, Poston L. Flow-mediated vasodilatation is enchanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997; 30:247-251.
65. 65 Barton M, Cremer J, Mügge A. 17β-Estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries. Eur J Pharmacol 1998; 362:73-76.
66. 66 Vedernikov Y, Saade G, Belfort M, Garfield RE. Effect of glycosylated hemoglobin on endothelium-dependent relaxation of omental arteries from pregnant women. Am J Obstet Gynecol 1998; 179:1047-1050.
67. 67 Hatake K, Kakishita E, Wakabayashi I, Sakiyama N, Hishida S. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 1990; 21:1039-1043.
68. 68 Nakashima M, Vanhoutte PM. Age-dependent decrease in endothelium-dependent hyperpolarizations to endothelin-3 in the rat mesenteric artery. J Cardiovasc Pharmacol 1993; 22(suppl 8):S352-S354.
69. 69 Mombouli JV, Lee SQ, Wasserstrum N, Vanhoutte PM. Endothelins 1 and 3 and big-endothelin-1 contract isolated human placental veins. J Cardiovasc Pharmacol 1993; 22(suppl 8):S278-S281.
70. 70 Lüscher TF, Cooke JP, Houston DS, Neves RJ, Vanhoutte PM. Endothelium-dependent relaxations in human arteries. Mayo Clin Proc 1987; 62:601-606.
71. 71 Buikema H, Pinto YM, Rooks G, Grandjean G, Schunkert H, van Gilst WH. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996; 17:787-794.
72. 72 Cipolla MJ, Harker CT, Porter JM. Endothelial function and adrenergic reactivity in human type-II diabetic resistance arteries. J Vasc Surg 1996; 23:940-949.
73. 73 Lüscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, et al. Difference between endothelium-dependent relaxations in arterial and in venous coronary bypass grafts. N Engl J Med 1988; 319:462-467.
74. 74 Thulesius O, Ugaily-Thulesius L, Neglen P, Shuhaiber H. The role of the endothelium in the control of venous tone: studies on isolated human veins. Clin Physiol 1988; 8:359-366.
75. 75 Katusic ZS, Shepherd JT, Vanhoutte PM. Endothelium-dependent contractions to calcium ionophore A23187, arachidonic acid and acetylcholine in canine basilar arteries. Stroke 1988; 19:476-479.
76. 76 Hishikawa K, Lüscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 1997; 96:3610-3616.
77. 2a receptors increase arterial endothelial cell nitric oxide. J Surg Res 1998; 80:357-364.
78. 78 Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Lüscher TF. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97:2494-2498.
79. 79 Cohen RA, Plane F, Najibi S, Huk I, Malinski T, Garland CJ. Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci USA 1997; 94:4193-4198.
80. 80 Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP. Circulation 1995; 92:3337-3349.
81. 81 Scheller M, Blobner M, Von Loewenich C, Schneck H, Stadler J, Franke C, et al. The NO synthase inhibitors L-NAME and L-NMMA, but not L-arginine, block the mammalian nicotinic acetylcholine receptor channel. Toxicol Lett 1998; 100/101:109-113.
82. 2 and prostacyclin. Pharmacol Rev 1979; 30:293-331.
83. 83 Lawrence RN, Clelland C, Beggs D, Salama FD, Dunn WR, Wilson VG. Differential role of vasoactive prostanoids in porcine and human isolated pulmonary arteries in response to endothelium-dependent relaxants. Br J Pharmacol 1998; 125:1128-1137.
84. 84 Karlsson C, Bodelsson G, Bodelsson M, Stjernquist M. Endothelium-derived prostanoids reduce 5-hydroxytryptamine-induced contraction in the human uterine artery. Hum Reprod 1997; 13:1947-1951.
85. 85 Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993; 92:2867-2871.
86. 86 Vanhoutte PM (editor). Endothelium-derived hyperpolarizing factor. Amsterdam: Harwood Academic Publishers; 1996.
87. 87 Vanhoutte PM (editor). Endothelium-dependent hyperpolarizations. Amsterdam: Harwood Academic Publishers; in press.
88. 88 Corriu C, Félétou M, Canet E, Vanhoutte PM. Endothelium derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol 1996; 119:959-964.
89. 89 Garland CJ, Plane F. Relative importance of endothelium-derived hyperpolarizing factor for the relaxation of vascular smooth muscle in different arterial beds. In: Vanhoutte PM (editor): Endothelium-derived hyperpolarizing factor. Amsterdam: Harwood Academic Publishers; 1996, pp. 173-179.
90. 90 Zygmunt PM, Högestätt ED. Endothelium-dependent hyperpolarization and relaxation in the hepatic artery of the rat. In: Vanhoutte PM (editor): Endothelium-derived hyperpolarizing factor. Amsterdam: Harwood Academic Publishers; 1996, pp. 191-201.
91. 91 Chataigneau T, Feletou M, Duhault J, Vanhoutte PM. Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br J Pharmacol 1998; 123:574-580.
92. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998 396:269-272.
93. 93 Chaytor AT, Evans WH, Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol 1998; 508(Pt2):561-573.
94. 94 Yamamoto Y, Fukuta H, Nakahira Y, Suzuki H. Blockade by 18β-glycyrrhetinic acid of intercellular electrical coupling in guinea-pig arterioles J Physiol 1998; 511:501-508.
95. 95 Taylor HJ, Chaytor AT, Evans WH, Griffith TM. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18β-glycyrrhetinic acid. Br J Pharmacol 1998; 125:1-3.
96. 96 Yamamoto Y, Imaeda K, Suzuki H. Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles. J Physiol 1999; 514:505-513.
97. 97 Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78:415-423.
98. 450 metabolite. J Vasc Res 1998; 35:274-284.
99. 99 Bauersachs J, Hocker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 1994; 113:1548-1553.
100. 100 Popp R, Bauersachs J, Hecker M, Fleming I, Busse R. A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol 1996; 497:699-709.
101. + channels. Circ Res 1998; 83:501-507.
102. 102 Félétou M, Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988; 93:515-524.
103. 103 Kemp BK, Cockx TM. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br J Pharmacol 1997; 120:757-762.
104. 104 Nagao T, Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to nitro-L-arginine in the arterial tree of the rat. Am J Physiol 1992; 263:H1O90-H1O94
105. 105 Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 1997; 100:2793-2799.
106. 106 Miller VM, Vanhoutte PM. Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclo-oxygenase in canine veins. Am J Physiol 1985; 248:H432-H437.
107. 107 Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8:344-348.
108. 108 Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989; 257:H33-H37.
109. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 1990; 15:699-703.
110. 110 Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s). Am J Physiol 1986; 250:H822-H827.
111. 111 Okatani Y, Watanabe K, Wakatsuki A, Tamura S, Sagara Y. Effects of superoxide and peroxynitrite on vascular tension in the human umbilical artery. Acta Obstet Gynecol Scand 1998; 77:883-888.
112. 112 Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989; 13:859-864.
113. 113 Taddei S, Vanhoutte PM. Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension 1993; 21:9-15.
114. 114 Auch-Schwelk, W, Katusic, ZS, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension 1992; 19:442-445.
115. 115 Miller FJ, Dellsperger KC, Gutterman DD. Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. Cardiovasc Res 1998; 38:744-750.
116. 116 Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997; 29:736-743.
117. 117 Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension 1997; 29(Pt2):274-279.
118. 118 Cardillo C, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolomic but not in hypertensive patients. Hypertension 1997; 30(Pt1):57-63.
119. 119 Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physioloy, and pathophysiology. Pharmacol Rev 1994; 46:325-415.
120. 120 Schini VB, Vanhoutte PM. Endothelin-1: a potent vasoactive peptide. Pharmacol Toxicol 1991; 69:1-7.
121. 121 Opgaard OS, Adner M, Gulbenkian S, Edvinsson L. Localization of ondothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 1994; 23:576-583.
122. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89:1203-1208.
123. 123 Miller VM, Komori K, Burnett JC Jr, Vanhoutte PM. Differential sensitivity to endothelin in canine arteries and veins. Am J Physiol 1989; 257:H1127-H1131.
124. 124 Lüscher TF, Boulanger CM, Yang Z, Dohi Y. Interaction between endothelin and endothelium-derived relaxing factor(s). In: Rubanyi G (editor): Endothelin. New York: Oxford University Press; 1992, pp. 125-136.
125. 125 Ahlborg G, Lundborg JM. Nitric oxide-endothelin-1 interaction in humans. J Appl Physiol 1997; 82:1593-1600.
126. 126 Flavahan N, Vanhoutte PM. Endothelial cell signaling and endothelial dysfunction. Am J Hypertens 1995; 8(suppl 5):28S-41S.
127. 127 Boulanger CM, Tanner FC, Bóa ML, Hahn AWA, Werner A, Lüscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70:1191-1197.
128. 128 Garlichs CD, Zhang H, Mügge A, Daniel WG. Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells. Eur J Clin Invest 1999; 29:12-16.
129. 129 Thorin E, Nguyen TD, Bouthillier A. Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke 1998; 29:175-180.
130. 130 Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96:3042-3047.
131. 131 Stepniakowski KT, Lu G, Davda RK, Egan BM. Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism. Hypertension 1997; 30:1634-1639.
132. 132 Henderson A. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol 1997; 62 (suppl 1):S43-S48.
133. 133 Lüscher TF, Noll G. Endothelial function as an end-point in international trials: concepts, methods and current data. J Hypertens 1996; 145 (suppl 2):S111-S121.
134. 134 Mullen MJ, Thorne SA, Deanfield JE. Non-invasive assessment of endothelial function. Heart 1997; 77:297-298.
135. 135 Uehata A, Lieberman EH, Gerhard MD, Andersen TJ, Ganz P, Polak JF, et al. Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vasc Med 1997; 2:87-92.
136. 136 Celermajer DS. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 1998. 32 (suppl 3):S29-S32.
137. 137 Lind L, Sarabi M, Millgärd J. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol 1998; 18:81-87.
138. 138 Mannion TC, Vita JA, Keaney JF, Benjamin EJ, Hunter L, Polak JF. Noninvasive assessment of brachial artery endothelial vasomotor function: the effect of cuff position on level of discomfort and vasomotor responses. Vasc Med 1998; 3:263-267.
139. 139 Playford DA, Watts GF. Special article: non-invasive measurement of endothelial function. Clin Exp Pharmacol Physiol 1998; 25:640-643.
140. 140 Berdeaux A, Ghaleh B, Dubois-Randé JL, Vigué B, Drieu La Rochelle C, Hittinger L, et al. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation 1994; 89:2799-2808.
141. 141 Vanhoutte PM, Verbeuren TJ, Webb RC. Local modulation of the adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev 1981; 61:151-247.
142. 142 Vanhoutte PM. Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle. Circ Res 1974; 34:317-326.
143. 143 Flavahan NA, Vanhoutte PM. Receptor-reserve and heterogeneity of vascular responses to vasodilator stimuli. In: Vanhoutte PM (editor): Vasodilatation: vascular smooth muscle peptides, autonomic nerves, and endothelium. New York: Raven Press; 1988, pp. 201-210.
144. 144 Corriu C, Félétou M, Canet E, Vanhoutte PM. Endothelium derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol 1996; 119:959-964.
145. 145 Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250:H1145-H1149.
146. 146 Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon III RO, Panza JA. Decrease vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension 1997; 30:918-921.
147. 147 Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/ nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation 1997; 95:2293-2297.
148. 2-and β-adrenergic responses in human forearm. J Clin Invest 1997; 100:2007-2014.
149. 2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature. Br J Clin Pharmacol 1999; 47:173-177.
150. 150 Weigert AL, Schini VB, Vanhoutte PM. Endothelium dependent potentiation of the relaxation of the rat aorta to isoproteronol. Role of inhibition of cyclic AMP phosphodiesterase by cyclic GMP. Pharmacol (Life Sci Adv) 1994; 13:45-52.
151. 151 Woo KS, McCrohon JA, Chook P, Adams MR, Robinson JTC, McCredie RJ, et al. Chinese adults are less susceptible than whites to age-related endothelial dysfunction. J Am Coll Cardiol 1997; 30:113-118.
152. 152 Cardillo C, Kilcoyne CM, Cannon III RO, Panza JA. Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. Hypertension 1998; 31:1235-1239.
153. 153 Cardillo C, Kilcoyne CM, Cannon III RO, Panza JA. Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation 1999; 99:90-95.
154. 154 Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Fujii H, et al. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997; 30:914-919.
155. G-monomethyl-L-arginine in men and women. Clin Sci 1997; 93:513-518.
156. 156 New G, Timmins KL, Duffy SJ, Tran BT, O'Brien RC, Harper RW, et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol 1997; 29:1437-1444.
157. 157 Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998; 32:730-734.
158. 158 McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ, Celermajer DS. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol 1998; 32:1331-1335.
159. 159 Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91:1981-1987.
160. 160 Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27:849-853.
161. 161 Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30(Pt1):252-258.
162. 162 Tsurumi Y, Nagashima H, Ichikawa KI, Sumiyoshi T, Hosoda S. Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine. J Am Coll Cardiol 1995; 26:1242-1250.
163. 163 O'Brien SF, Watts GF, Playford DA, Burke V, O'Neal DN, Best JD. Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependem diabetes. Diabetic Med 1997; 14:974-978.
164. 164 Schächinger V, Halle M, Minners J, Berg A, Zeiher AM. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol 1997; 30:927-934.
165. 165 Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 1997; 96:3287-3293.
166. 166 Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997; 100:1230-1239.
167. 167 Tanaka S, Yashiro A, Nakashima Y, Nanri H, Ikeda M, Kurowa A. Plasma nitrite/nitrate levels is inversely correlated with plasma low-density lipoprotein cholesterol level. Clin Cardiol 1997; 20:361-365.
168. 168 Schlaich MP, John S, Langenfeld MRW, Lackner KJ, Schmitz G, Schmieder RE. Does lipoprotein(a) impair endothelial function? J Am Coll Cardiol 1998; 31:359-365.
169. 169 Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26:1235-1241.
170. 170 Tagawa T, Mohri M, Tagawa H, Egashira K, Shimokawa H, Kuga T, et al. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. J Cardiovasc Pharmacol 1997; 29:546-553.
171. 171 Hladovec J, Prevovsky I. Endothelial lesion inhypertension. Cor Vasa 1989; 31:51-54.
172. 172 Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J. Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 37:7-11.
173. 173 Stehouwer CDA, Fisher HRA, van Kuijk AWR, Polak BCP, Donker AJM. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 1995; 44:461-564.
174. 174 Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34:55-68.
175. 175 Tsakiris DA, Tschöpl M, Jäger K, Haefeli WE, Wolf F, Marbet GA. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142:193-200.
176. 176 Jern S, Wall U, Bergbrant A, Selin-Sjögren L, Jern C. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol 1997; 17:3376-3383.
177. 177 Kuwasako K, Kida O, Kitamura K, Kato J, Eto T. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury. Int Angiol 1997; 16:272-279.
178. 178 Smulders RA, Stehouwer CDA, Olthof CG, Van Kamp GJ, Teerlink T, De Vries PMJM, et al. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994; 87:37-43.
179. 179 Mangiafico RA, Malatino LS, Santonocito M, Spada RS, Polizzi G, Tamburino G. Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis. Int Angiol 1996; 15:240-244.
180. 180 Poveda JJ, Riestra A, Salas E, Cagigas ML, López-Somoza C, Amado JA et al. Contribution of nitric oxide to exercise-induced changes in healthy volunteers. Effects of acute exercise and long-term physical training. Eur J Clin Invest 1997; 27:967-971.
181. 181 Hwang YS, Hsieh TJ, Lee YJ, Tsai JH. Circadian rhythm of urinary endothelin-1 excretion in mild hypertension patients. Am J Hypertens 1998; 11:1344-1351.
182. 182 Leppert J, Ringqvist A, Karlberg BE, Ringqvist I. Whole-body cooling increases plasma endothelin-1 levels in women with primary Raynaud's phenomenon. Clin Physiol 1998; 18:420-425.
183. 183 Kelm M, Preik-Steinhoff H, Preik M, Strauer BE. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res 1999; 41:765-772.
184. 184 Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95:2068-2074.
185. 185 Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 1998; 98:1842-1847.
186. 186 Miyagaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis. Circulation 1999; 99:1141-1146.
187. 187 Fink J, Fan NYT, Rosenfeld L, Stier CT. Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 1998; 31:618-622.
188. 188 Ming Z, Parent R, Thorin E, Lavallée M. Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs. Hypertension 1998; 32:844-848.
189. 189 Wang OD, Gonon A, Shimizu M, Sjöquist PO, Pernow J. Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition. Acta Physiol Scand 1998; 163:325-330.
190. 190 Kahn F, Davidson NC, Littleford RC, Litchfield SJ, Struthers AD, Belch JJF. Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in man. Vasc Med 1997; 2:82-86.
191. 191 Duffy SJ, Tran BT, New G, Tudball RN, Esler MD, Harper RW, et al. Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans. Am J Physiol 1998; 274:H1174-H1183.
192. 192 Duffy SJ, New G, Tran BT, Harper RW, Meredith IT. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999; 276:H663-H670.
193. 193 Taddei S, Ghadoni L, Virdis A, Salvetti A. Vasodilatation to bradykinin is mediated by an endothelium-derived hyperpolarizing factor in essential hypertensive patients. In: Vanhoutte PM (editor): Endothelium-dependent hyperpolarizations. Amsterdam: Harwood Academic Publishers; 1999, pp. 381-390.
194. 194 Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 1998;97:716-720.
195. 195 Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39:287-324.
196. 196 Freedman JE, Loscalzo J. Endothelial dysfunction and athero-thrombotic occlusive disease. Drugs 1997; 54 (suppl 3):41-50.
197. 197 Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997; 80:111-161.
198. 198 Lyons D. Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease. Int J Cardiol 1997; 62 (suppl 2):S101-S109.
199. 199 Bell DM, Johns TE, Lopez LM. Endothelial dysfunction: implications of therapy of cardiovascular diseases. Ann Pharmacother 1998; 32:459-470.
200. 200 Pepine CJ. Clinical implications of endothelial dysfunction. Clin Cardiol 1988; 21:795-799.